HomeCompareBLSFF vs MRK

BLSFF vs MRK: Dividend Comparison 2026

BLSFF yields 3.99% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BLSFF wins by $1780.05M in total portfolio value
10 years
BLSFF
BLSFF
● Live price
3.99%
Share price
$16.49
Annual div
$0.66
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1780.11M
Annual income
$1,698,309,364.65
Full BLSFF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — BLSFF vs MRK

📍 BLSFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBLSFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BLSFF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BLSFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BLSFF
Annual income on $10K today (after 15% tax)
$339.02/yr
After 10yr DRIP, annual income (after tax)
$1,443,562,959.95/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, BLSFF beats the other by $1,443,554,363.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BLSFF + MRK for your $10,000?

BLSFF: 50%MRK: 50%
100% MRK50/50100% BLSFF
Portfolio after 10yr
$890.08M
Annual income
$849,159,739.21/yr
Blended yield
95.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BLSFF
No analyst data
Altman Z
4.7
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BLSFF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBLSFFMRK
Forward yield3.99%2.81%
Annual dividend / share$0.66$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$1780.11M$57.7K
Annual income after 10y$1,698,309,364.65$10,113.78
Total dividends collected$1774.26M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BLSFF vs MRK ($10,000, DRIP)

YearBLSFF PortfolioBLSFF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,498$797.70$11,213$373.04+$285.00BLSFF
2$14,017$1,714.33$12,667$512.06+$1.4KBLSFF
3$18,904$3,906.43$14,439$708.14+$4.5KBLSFF
4$30,076$9,847.83$16,640$988.16+$13.4KBLSFF
5$61,465$29,284.42$19,432$1,394.07+$42.0KBLSFF
6$177,634$111,866.11$23,057$1,992.90+$154.6KBLSFF
7$794,352$604,283.34$27,889$2,894.79+$766.5KBLSFF
8$5,900,912$5,050,955.70$34,518$4,286.29+$5.87MBLSFF
9$76,447,566$70,133,589.76$43,912$6,494.35+$76.40MBLSFF
10$1,780,108,260$1,698,309,364.65$57,714$10,113.78+$1780.05MBLSFF

BLSFF vs MRK: Complete Analysis 2026

BLSFFStock

BlueScope Steel Limited produces and sells metal coated and painted steel building products in Australia, New Zealand, Asia, North America, and internationally. The company operates through five segments: Australian Steel Products, North Star BlueScope Steel, Building Products Asia & North America, Buildings and Coated Products North America, and New Zealand & Pacific Islands. It offers steel slabs, plates, hot and cold rolled coils, coated and painted strip products, roof and wall claddings, and purlins and house framings under the LYSAGHT steel building products, COLORBOND steel, COLORSTEEL, ZINCALUME steel, GALVABOND steel, GALVASPAN steel, BlueScope Zacs, and SuperDyma brands. The company also provides engineered building solutions to industrial and commercial markets under the Butler, Varco Pruden, EcoBuild, and PROBUILD brands. It serves customers in the residential and non-residential building, construction, manufacturing, automotive and transport, agricultural, and mining industries directly, as well as through a network of service centers and steel distribution businesses. The company was formerly known as BHP Steel Limited and changed its name to BlueScope Steel Limited in November 2003. BlueScope Steel Limited was founded in 1885 and is headquartered in Melbourne, Australia.

Full BLSFF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BLSFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BLSFF vs SCHDBLSFF vs JEPIBLSFF vs OBLSFF vs KOBLSFF vs MAINBLSFF vs JNJBLSFF vs ABBVBLSFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.